Tasso, Inc. Joint Venture Receives Controlled Medical Device Approval in Japan for Novel Self-Administered Blood Collection Device
Certification clears path in Japan for wider access to preventive medicine, telemedicine, and reduced provider burden
SEATTLE – September 9, 2025 – Tasso, Inc., the leading provider of patient-centric, clinical-grade blood collection solutions, today announced that the TS Blood Collection Kit, a product of Tasso-SNBL, Ltd., received certification as a controlled medical device under Japan’s Pharmaceuticals and Medical Devices Act. This certification was conducted by a third-party certification body registered with the Ministry of Health, Labour and Welfare (MHLW) and confirms the product’s safety, performance, and quality control system comply with relevant regulations.
The TS Blood Collection Kit integrates Tasso’s signature lancet technology with a compatible collection reservoir to deliver a virtually painless, self-administered solution for collecting high-quality blood samples. Designed for use anywhere, including at home, the kit minimizes patient discomfort while ensuring reliable results for healthcare providers.
